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Abstract The enzyme component of the actin ADP-ribosylating 
Clostridium perfringens iota toxin was affinity labelled by UV 
irradiation in the presence of [carbonyl-14C]NAD. A peptide 
containing the radiolabel was generated by CNBr cleavage and 
subsequent proteolysis with trypsin. Its amino acid sequence is 
Gly-Ser-Pro-Gly-Ala-Tyr-Leu-Ser-Ala-Ile-Pro-Gly-Tyr-Ala-G- 
ly-X-Tyr-Glu-Val-Leu-Leu-Asn-His-Gly-Ser-Lys corresponding 
with the region Gly-363 through Lys-388 in the C. perfringens 
iota toxin. Mass spectrometric data as well as the results of the 
PTH-amino acid analysis are in line with a modification of a 
glutamic acid side chain located at position 378. Therefore, in 
addition to Glu-380, as could be concluded by analogy with other 
ADP-ribosyltransferases, Glu-378 may play a pivotal role in the 
active site of C. perfringens iota toxin. 
1. Introduction 
Clostridium perfringens iota toxin belongs to a family of 
actin-ADP-ribosylating toxins [1]. Other members of this fa- 
mily are C. botulinum C2 toxin [2] and C. spiroforme toxin 
[3,4] (for review see [5,6]). These toxins are binary in structure 
and consist of a binding component and an enzyme compo- 
nent that interact at the surface of target cells. It is suggested 
that the toxins enter cells by receptor-mediated ndocytosis 
[7,8] followed by a cascade of processes which, finally, result 
in translocation of the enzyme components into the cytosol. 
In the target cell, the enzyme component ADP-ribosylates 
monomeric G-actin at Arg-177 [9,10]. ADP-ribosylation inhi- 
bits actin polymerisation [1,2], actin ATPase activity [11] and 
turns actin into a capping protein that binds to the barbed 
ends of actin filaments inhibiting fast polymerisation [12]. 
Although both iota toxin and C2 toxin modify actin at the 
same amino acid residue, both toxins differ in their substrate 
specificity. Iota toxin modifies all actin isoforms studied so 
far, whereas C2 toxin ADP-ribosylates non-muscle 13/'/actins 
and T-smooth muscle actin but not a-actin isoforms [13]. 
Significant progress in the understanding of the action of 
bacterial ADP-ribosylating toxins and of the underlying mo- 
lecular mechanisms were obtained by crystal structure ana- 
lyses of Pseudomonas exotoxin A [14], diphtheria toxin [15], 
E. coli heat labile toxin [16] and pertussis toxin [17]. These 
studies suggested that despite rather poor similarity in the 
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primary sequence, ADP-ribosylating toxins share a common 
active site structure. 
Here we have located the active site sequence of the enzyme 
component of iota toxin using photo-affinity labelling in the 
presence of [carbonyl-14C]NAD and microsequencing analy- 
sis. The amino acid sequence around the labelled active site 
shows a striking similarity with corresponding regions in the 
C3-1ike ADP-ribosyltransferases. Our studies support the im- 
portance of two glutamic acid residues in the active site. 
2. Materials and methods 
2.1. Materials 
NAD was from Boehringer Mannheim (Germany). [carbonyl- 
14C)NAD (54 mCi/mmol) was obtained from Amersham Corp. All 
other reagents were from commercial sources and analytical grade. 
Rabbit skeletal muscle actin was purified as described [18]. 
2.2. Purification of C. perfringens iota toxin 
The ADP-ribosylating component of iota toxin was purified by a 
two step procedure from the culture supernatant of C. perfringens 
type E strain CN 5063, which was kindly donated by Dr. S. Thorley 
(Wellcome Beckenham, Kent, UK). The culture supernatant was pre- 
cipitated with ammonium sulphate (70% saturation). The collected 
pellets were extracted with 50 mM Tris-HC1, pH 7.5, followed by 
dialysis against buffer containing 10 mM Tris-HCl, pH 7.5. The 
ADP-ribosylating component was recovered in the flow-throw of a 
DEAE Sephadex anion exchange chromatography and was subse- 
quently concentrated by membrane filtration (Amicon). The enzyme 
component of iota toxin was more than 95% pure (Fig. 1). 
2.3. ADP-ribosylation assay 
ADP-ribosylation reactions were carried out essentially as described 
[1,19]. Briefly, iota toxin (enzyme component, 1 ~tg/ml) was incubated 
in a medium containing 1 mM dithiothreitol, 50 laM MgCI2, 50 ~M 
[32P]NAD (0.5 ~tCi), 50 mM triethanolamine, pH 7.5, and 5 ~M 
rabbit skeletal muscle a-actin for 45 min at 37°C. For determination 
of the specific activity the incubation time was kept at 4 min. ADP- 
ribosylated actin was separated on 11% SDS-PAGE and detected with 
a Phosphorimager (Molecular Dynamics). 
2.4. Photo-affinity labelling of C. perfringens iota toxin 
600 I.tl of C. perfringens iota toxin (1 mg/ml, in 25 mM ammonium 
bicarbonate) was incubated with 100 laM [14C]NAD for 30 rain at 4°C 
followed by UV irradiation (254 nm, 3 cm distance, 3000/.tW/cm 2) for 
2 h. Thereafter, the amount of incorporated label was determined by 
precipitation of iota toxin with trichloroacetic a id (20%, w/v), sub- 
sequent filtration onto nitro-cellulose filters and counting for retained 
radioactivity. Irradiated iota toxin was separated from unreacted 
NAD by HPLC chromatography using a Sephasil RP-CI8 2.1 × 100 
mm column (Pharmacia) and lyophilised. 
CNBr-cleavage was performed in 70% formic acid with a >300-fold 
molar excess of CNBr over protein. The mixture was incubated in the 
dark for 24 h at room temperature followed by evaporation in 
a Speed Vac (Savant) apparatus. Remaining CNBr and acid were 
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removed by subsequent lyophilization after resuspending in water. 
The CNBr-fragment mixture was then further digested with trypsin 
(enzyme substrate ratio: 1/50, by weight) in 0.1 M Tris-HC1 buffer 
(pH 8.5) at 37°C overnight. The resulting peptides were separated by 
reverse-phase HPLC chromatography using a C-18 Vydac 2.1 ×250 
mm column. Peptides were eluted with a gradient of 0% B to 80% B in 
90 min (solvent A: 0.1% TFA in water (v/v); solvent B: 0.1% TFA in 
70% acetonitril in water (v/v). Twenty percent of the outlet flow was 
directed into the ion source of an electrospray ionization mass pec- 
trometer (VG Platform, Fisons Instruments, Manchester, UK), on- 
line connected with the HPLC system (140A Solvent delivery system, 
Applied Biosystems). The remaining 80% of the eluate was directed 
into a 759 A absorbance detector, Applied Biosystems) and peptides 
were detected at 216 nm and manually collected. Twenty percent of 
each of the collected peaks was removed, dried in vacuo and the 
radioactivity measured after mixing with 150 I, tl scintillation liquid. 
2.5. Amino acid sequence analysis 
The 14C-labelled peptide peak was selected for sequence analysis. 
This was carried out with an Applied Biosystems model 477A Protein 
Sequencer with an on-line model 120A PTH analyzer. The instrument 
was run with the standard programme according to the manufac- 
turer's instructions. A constant aliquot (40%) of the PTH-derivative 
formed in each cycle was directed into a fraction collector for radio- 
activity counting. 
3. Results and Discussion 
When purified iota toxin was UV-irradiated in the presence 
of [i4C]NAD, about 25-30% of iota toxin was labelled. At this 
stage the enzyme activity was completely inhibited (not 
shown). Interestingly irradiation in the absence of NAD 
also caused full inhibition of transferase activity, suggesting 
a high sensitivity to UV irradiation, even after short exposure 
times (e.g. 30 min). To determine the amino acid residue 
which was affected, the labelled transferase was first cleaved 
by CNBr followed by trypsin digestion. Peptides formed were 
separated by reverse phase HPLC. As shown in Fig. 2A, only 
one major labelled peptide was detected. It was subjected to 
amino acid sequence analysis and the following results were 
obtained: Gly-Ser-Pro-Gly-Ala-Tyr-Leu-Ser-Ala-Ile-Pro-Gly- 
Tyr-Ala-Gly-X-Tyr-Glu-Val-Leu-Leu-Asn-His-Gly-Ser-Lys 
(Fig. 2B). 
This sequence corresponds with residues Gly-363 through 
Lys-388 of the mature C. perfringens enzyme as published [20] 
and corrected recently [21]. Note that Gly is at position 363 of 
the iota toxin from the C. perfringens train CN 5063, whereas 
Asp is at this site in strain 10768 which was used to derive the 
published sequence [20]. Residue X, carrying the radiolabel, 
eluted as an 'unconventional' PTH-derivative with a retention 
time between dimethylphenylthiourea and PTH-Ala (Fig. 3A). 
This is exactly as previously noted in the course of similar 
analyses of the ADP-ribosyltransferases of Clostridium limo- 
sum [22] and of Bacillus cereus [23], where sequencing of the 
unmodified peptide or DNA-sequence predicted a glutamic 
acid residue. Also in the case of the iota toxin, we notice a 
glutamic acid in the corresponding DNA-sequence at the site 
of the modified residue [21]. 
It is known that the nicotinamide moiety of NAD + can be 
cross-linked by UV-irradiation to the 7-methylene carbon 
formed by decarboxylation f the pivotal glutamic acid in 
the active centre of the transferase [24]. This leads to an in- 
crease of the mass by 76 Da [24]. Mass spectrometric analysis 
of the labelled peptide revealed a mass of 2729 Da, corre- 
sponding with the expected modification in the Gly-363- 
Lys-388 peptide (Fig. 3B). 
Thus, two lines of evidence support the conclusion that 
Glu-378 represents he modified residue: first, a characteristic 
modified PTH-residue is identified at this position and second, 
the increase in mass of the tryptic peptide corresponds very 
well with a conjugate formed between glutamic acid and the 
nicotinamide moiety. 
Interestingly, Glu-378 is located within a region of signifi- 
cant homology with a number of ADP-ribosyl transferases. 
This list includes C3-1ike transferases [25 29], cholera toxin 
[30], the family of Rhodospirillum-like ADP-ribosyltrans- 
ferases [31], the T2, T4, T6 bacteriophage transferases [32] 
and several recently identified eukaryotic glycosylphosphati- 
dylinositol-anchored mono-ADP-ribosyltransferases (or 
NAD-ases) such as the rabbit muscle ADP-ribosyltransferase 
[33-35] and the family of RT6-1ike T-cell alloantigens [36-38]. 
An alignment of these sequences i shown in Fig. 4. The 
most conserved residue in this region is a glutamic acid resi- 
due consistently followed by a very hydrophobic tripeptide 
sequence. This Glu-residue seems pivotal for catalysis ince 
it can be cross-linked by UV-irradiation to nicotinamide, con- 
comitant with inhibition of ADP-ribosyltransferase activity. 
This is the case for Glu-148 of diphtheria toxin [39], Glu- 
553 of Pseudomonas exotoxin A [40], Glu-129 of the S1 sub- 
unit of the pertussis toxin [41] which all seem functionally 
equivalent. Photoaffinity-labelling and site-directed mutagen- 
esis similarly identified Glu-174 of the C3-1ike C.limosum 
transferase as part of the active site [22,28]. Finally, it was 
shown that the C3-1ike transferase from B. cereus could be 
modified at a functionally and structurally equivalent residue 
[23]. 
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Fig. 1. SDS-PAGE analysis of the ADP-ribosylating component of 
C. perfringens iota toxin. Iota toxin was purified from culture super- 
natant (lane 1) of C. perfringens Type E strain CN5063 by ammo- 
nium sulphate precipitation (70%), lane 2) and subsequent DEAE- 
anion exchange chromatography (lane 3) as described in section 2. 
J. van Damme et al./FEBS Letters 380 (1996) 291-295 293 
A 
600 
| 
? 50f l  
E 40f l  
Q.  
(.I 
3011 
20C 
10C 
? 
peak fraettons 
140 
loo  
E so 
6O 
4a  
20  
0 p i F I I r I I I I I I I I I I I I I I I I I I I I 
G S P G A Y L S A i P G Y A G "X" Y E V L L N H G S K 
a amino  ac~ls  
Fig. 2. (A) Elution profile of the peptides from the irradiated en- 
zyme component of C. perfringens iota toxin. The enzyme compo- 
nent of C. perfringens iota toxin was UV irradiated in the presence 
of [carbonylJ4C]NAD for 120 min. Thereafter, the labelled transfer- 
ase was isolated by chromatography and cleaved by CNBr and sub- 
sequently digested with trypsin. The peptides were analysed by 
HPLC chromatography as described. Elution profiles of proteolytic 
peptides ( - - ) ;  radioactivity (©) was determined in an aliquot of 
the eluting fractions. Most radioactivity was recovered in fraction 
49 (arrow). (B) Amino acid sequence analysis and measurement of
radioactivity in the residues of the 14C-labelled proteolytic peptide 
(fraction 49) from C. perfringens iota toxin. The abscissa gives the 
amino acids determined; the radioactivity is given on the ordinate. 
A similar (G1u-380) conserved residue followed by a hydro- 
phobic tripeptide is found in the labelled peptide of the iota- 
toxin, but unexpectedly not Glu-380 but Glu-378 was now 
labelled. This observation came to us somewhat as a surprise 
in view of the constant observations of a functional Glu ad- 
jacent to the hydrophobic cluster (see above). Enzymes with a 
similarly spaced biglutamic acid sequence are the transferases 
of cholera toxin, the E. coli heat-labile toxins, the mosquito- 
cidal toxin from B. sphaericus, T2-1ike transferases, Rhodos- 
pirillum-like transferases, the rat T cell alloantigen RT6 and 
rabbit muscle ADP-ribosyltransferase (Fig. 3). For none of 
them, a similar labelling experiment has been performed, 
and it is not known if our observation could also apply to 
the other enzymes, 
In answering this question it is interesting that mutant E. 
coli heat labile toxin in which the glutamic acid residues at 
either position 110 and 112 are replaced with aspartic acid 
exhibits severely reduced enzyme activity [42]. Furthermore, 
these findings are in good agreement with mutational analysis 
carried out on rabbit muscle ADP-ribosyltransferases showing 
three consecutive Glu-residues (Glu-238, Glu-239, Glu-240) in 
a region corresponding to that identified in the iota toxin 
sequence [33,35]. When in this transferase either Glu-238 or 
Glu-240 is exchanged by Asp, a drastic reduction in enzymatic 
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Fig. 3. (A) HPLC-tracing of the separations of the phenylthiohy- 
dantoin (PTH) amino acid residues released in cycles 15 through 19 
during the automated Edman degradation of peptide collected from 
49. The upper panel shows the standard PTH-residues. Amino acid 
derivatives are indicated by the standard one-letter notation. X in 
cycle 16 denotes the modified residue: most likely the Glu-nicotina- 
mide conjugate. The asterisk indicates the position of dimethylphe- 
nylthiourea; a full circle: the position of diphenylthiourea. (B) Mass 
spectrum of the peptide nicotinamide conjugate. A2, A3, and A4 in- 
dicate the positions of the doubly, triply, and quadruply charged 
ions, respectively. The deduced molecular mass is shown. The x-axis 
represents the mass over charge ratio (m/z) while the y-axis mea- 
sures the ion intensity. 
294 J. van Damme et al./FEBS Letters 380 (1996) 291-295 
activity is noticed [35]. In contrast, substitution of Glu-239 by 
Asp has almost no effect. These studies suggest hat the simi- 
larly spaced glutamic acid residues participate in the catalytic 
activity. In the 'mono'-glutamic a id transferases, the second 
glutamic acid position is often occupied bv glutamine, or in 
individual cases by arginine or serine: residues that may par- 
ticipate in hydrogen bond formation. It is thus possible that 
this residue also actively participates in the reaction, but only 
when it is a glutamic acid residue, a covalent link can be 
formed by UV-irradiation. In view of the above results, it is 
tempting to conclude that the strictly conserved Glu-residue 
and the second preceding Glu-residue are important for cata- 
lytic activity. 
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Fig. 4. Comparison of the amino acid sequences of the region adja- 
cent to a glutamic acid residue suggested to be involved in catalysis 
of the ADP-ribosylation by various transferases (Lim, C. limosum 
ADP-ribosyltransferase [28]; C3N, C. botulinum C3 transferase [26]; 
C3P, C. botulinum C3 transferase [25]; EDIN, S. aureus transferase 
[27]; Cer, B. cereus transferase [23]; CT, cholera toxin [30]; LT, 
E. coli heat labile toxin [43]; MTX, mosquitocidal toxin from 
B. sphaericus [44]; PT, pertussis toxin [45]; T2, bacteriophage ADP- 
ribosyltransferase T2 [32]; mRT6, mouse homologue of the rat T 
cell alloantigen RT6 [46]; rMT, rabbit muscle ADP-ribosyltransfer- 
ase [33]; ETA, Pseudomonas exotoxin A [47]; DT, diphtheria toxin 
[481. 
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